V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017541 | 160008718 | 1.68 | 61.8 | null | 2021-11-24 | 2021-11-24 | IVADo | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101510823 |
| 160017543 | 160008719 | 1.67 | 56.9 | Palliative (P) | 2020-02-03 | 2020-02-08 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100766544 |
| 160017545 | 160008720 | 1.75 | 62.2 | Palliative (P) | 2018-11-21 | 2018-11-21 | Doxorubicin 75mg/m2 | 01 | Y | DOXORUBICIN | 101079614 |
| 160017546 | 160008721 | 1.75 | 72.9 | null | 2019-10-16 | 2019-10-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100868010 |
| 160017547 | 160008722 | 1.74 | 79.5 | Curative (C) | 2015-09-03 | 2015-09-09 | PEMBROLIZUMAB | 99 | N | SUNITINIB | 101523661 |
| 160017548 | 160008723 | 0.02 | 71.6 | Curative (C) | null | 2016-08-10 | Doxorubicin 75mg/m2 | null | N | DOXORUBICIN | 100915208 |
| 160017549 | 160008724 | 1.62 | 127.9 | Palliative (P) | 2017-02-03 | 2017-02-15 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101085284 |
| 160017550 | 160008725 | 1.81 | 72 | Curative (C) | 2018-09-02 | 2018-09-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101050889 |
| 160017553 | 160008726 | 1.64 | 81 | Neo-adjuvant (N) | 2019-02-03 | 2019-02-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | DOXORUBICIN | 101205099 |
| 160017554 | 160008727 | null | null | Curative (C) | 2019-11-09 | 2019-11-16 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101244428 |
| 160017555 | 160008728 | 1.83 | 75.3 | Palliative (P) | 2019-07-07 | 2019-07-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100460495 |
| 160017556 | 160008729 | 0 | 9.3 | Palliative (P) | 2019-09-08 | 2019-09-17 | GEMCITABINE | 02 | N | LIPOSOMAL DOXORUBICIN | 101502820 |
| 160017558 | 160008730 | 1.67 | 58 | Palliative (P) | 2019-06-30 | 2019-08-29 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101162573 |
| 160017560 | 160008731 | 1.76 | null | Palliative (P) | 2016-09-26 | 2016-09-27 | Doxorubicin + Ifosfamide | 02 | N | ENZALUTAMIDE | 100911780 |
| 160017563 | 160008732 | 1.79 | 90.4 | Curative (C) | 2019-05-25 | 2019-06-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | DOXORUBICIN + OLARATUMAB | 100927757 |
| 160017564 | 160008733 | 1.68 | 66.1 | Palliative (P) | 2018-10-20 | 2018-10-29 | IVADo | 02 | N | DOCETAXEL + GEMCITABINE | 101163188 |
| 160017565 | 160008734 | null | null | Palliative (P) | 2019-07-04 | 2019-07-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101024383 |
| 160017566 | 160008735 | 1.73 | 95 | Palliative (P) | 2017-07-27 | 2017-07-28 | IDARUBICIN | null | N | DOXORUBICIN + IFOSFAMIDE | 100452181 |
| 160017569 | 160008736 | 1.58 | 50.6 | Palliative (P) | 2016-12-05 | 2016-12-09 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101054433 |
| 160017571 | 160008737 | 1.48 | 56.9 | null | 2018-10-15 | 2018-11-11 | MELPHALAN | N | N | ICON8B TRIAL | 101033478 |
| 160017572 | 160008738 | 1.67 | 77.9 | null | 2018-01-16 | 2018-01-16 | Cisplatin + Pemetrexed | null | null | CISPLATIN + PEMETREXED | 100013877 |
| 160017573 | 160008739 | 1.72 | 52.1 | Palliative (P) | 2016-03-23 | 2016-04-01 | Doxorubicin 75mg/m2 | null | null | DOXORUBICIN | 100093601 |
| 160017574 | 160008740 | 1.76 | 82 | Palliative (P) | 2018-09-02 | 2018-09-27 | Capecitabine | 02 | N | TRIAL | 100429582 |
| 160017581 | 160008742 | 1.68 | 88.8 | Palliative (P) | 2016-09-21 | 2016-10-15 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101161754 |
| 160017582 | 160008743 | 1.66 | 106 | Palliative (P) | 2019-06-20 | 2019-07-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101358586 |
| 160017586 | 160008745 | 1.52 | 64.8 | Palliative (P) | 2016-11-13 | 2016-11-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101030768 |
| 160017587 | 160008746 | 1.65 | 128 | Neo-adjuvant (N) | null | 2019-07-20 | LIPOSOMAL DAUNORUBICIN | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100950735 |
| 160017588 | 160008747 | 1.7 | 97 | Neo-adjuvant (N) | null | 2018-11-01 | Epirubicin (weekly) | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100767356 |
| 160017589 | 160008748 | null | 73 | Palliative (P) | 2016-06-29 | 2016-07-20 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101010455 |
| 160017591 | 160008749 | 1.74 | 92 | Curative (C) | 2017-03-11 | 2017-04-11 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | CARBOPLATIN + GEMCITABINE | 101614177 |
| 160017592 | 160008750 | 1.66 | 63.3 | Palliative (P) | 2017-03-07 | 2017-03-21 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | DOXORUBICIN + OLARATUMAB | 100268541 |
| 160017593 | 160008751 | 1.63 | 76.35 | Palliative (P) | 2019-12-09 | 2019-12-15 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100107308 |
| 160017595 | 160008752 | 1.72 | 71.85 | Curative (C) | 2019-07-12 | 2019-07-13 | Trabectedin | N | N | DOXORUBICIN + IFOSFAMIDE | 101519402 |
| 160017598 | 160008753 | 1.69 | 101.4 | Palliative (P) | 2018-11-09 | 2018-11-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | EPIRUBICIN | 101167241 |
| 160017604 | 160008754 | 1.58 | 52.7 | Palliative (P) | 2018-06-22 | 2018-06-23 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101663511 |
| 160017605 | 160008755 | 1.76 | 73.7 | Curative (C) | 2018-03-07 | 2018-03-21 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100466412 |
| 160017607 | 160008756 | 1.79 | 81.25 | null | 2017-12-10 | 2017-12-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100578964 |
| 160017608 | 160008757 | 1.76 | 71.3 | Curative (C) | 2019-05-13 | 2019-05-19 | MELPHALAN | N | N | NOT MATCHED | 100729000 |
| 160017610 | 160008758 | 1.86 | 63.6 | Palliative (P) | 2018-12-06 | 2018-12-15 | Doxorubicin + Ifosfamide | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100706943 |
| 160017611 | 160008759 | null | null | Palliative (P) | 2018-03-03 | 2018-03-18 | VIDE | 02 | N | ETOPOSIDE + RITUXIMAB | 100427447 |
| 160000134 | 160008760 | 1.78 | 67.4 | Neo-adjuvant (N) | 2018-11-27 | 2018-12-01 | Trial Unspecified | 02 | N | LIPOSOMAL DOXORUBICIN | 101258877 |
| 160000286 | 160008761 | 1.53 | null | null | 2017-05-15 | 2017-05-16 | Carboplatin AUC 2 - 5 | 02 | Y | CARBOPLATIN | 100422236 |
| 160000338 | 160008762 | 1.77 | 77 | Palliative (P) | 2019-11-06 | 2019-11-14 | DOXORUBICIN | null | N | PEMBROLIZUMAB | 100434819 |
| 160000341 | 160008763 | 1.78 | 89.5 | Palliative (P) | null | 2019-02-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100944148 |
| 160000491 | 160008764 | 1.8 | 101.6 | null | 2019-12-01 | 2019-12-08 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100616604 |
| 160000825 | 160008765 | 1.6 | 56 | Palliative (P) | 2021-02-22 | 2021-03-24 | Docetaxel+Gemcitabine (no prior RT) | N | N | DOXORUBICIN + IFOSFAMIDE | 100904085 |
| 160000895 | 160008766 | 1.5 | 93 | Neo-adjuvant (N) | 2019-06-08 | 2019-06-11 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | CARBOPLATIN + PACLITAXEL | 100855895 |
| 160000937 | 160008767 | 1.73 | 67.6 | Curative (C) | 2019-04-27 | 2019-05-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100945451 |
| 160001486 | 160008768 | 1.66 | null | Not known (9) | 2020-01-03 | 2020-01-04 | Carboplatin AUC 6 - 10 | N | N | CARBOPLATIN | 101068815 |
| 160001510 | 160008769 | 1.8 | 80.5 | Palliative (P) | 2020-07-30 | 2020-07-30 | EW EuroEwing 2012 Arm B VDC | N | N | CISPLATIN + GEMCITABINE | 101365304 |